Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer

Psychoneuroendocrinology

Volumn 21, Issue 4, 1996, Pages 361-374

  Van Der Pompe, Gieta ^a   Antoni, Michael H ^b   Heijnen, Cobi J ^c  

^a HELEN DOWLING INSTITUTE   (Netherlands)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ACTH; Acute stress; Breast cancer; Cortisol; HPA axis; Prolactin

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; PROLACTIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; PRIORITY JOURNAL; STRESS;

EID: 0030152081     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4530(96)00009-1     Document Type: Article

References (49)

1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561-571.
2. Benschop RJ, Brosschot JF, Godaert GLR, de Smet MBM, Geenen R, Olff M, Heijnen CJ, Ballieux RE (1994) Chronic stress affects immunologic but not cardiovascular responsiveness to acute psychological stress in man. Am J Physiol 266:75-80.
3. Benton E, Bryant HU, Holaday JW (1991) Prolactin and immune function. In: Ader R, Felten DL, Cohen N (Eds) Psychoneuroimmunology II, Academic Press, New York, pp 403-420.
4. Berger M, Bossert S, Krieg JC, Dirlich G, Ettmeier W, Schreiber W, Zerssen D von (1987) Inter-individual differences in the susceptibility of the cortisol system: an important factor for the degree of hypercortisolism in stress situations. Biol Psychiatry 22:1327-1339.
5. Berry J, Green B, Matheson D (1987) Modulation of natural killer cell activity by tamoxifen in stage 1 postmenopausal breast cancer patients. Eur J Cancer Clin Oncol 23:517-520.
6. Biller BMK, Federoff HJ, Koenig JI, Klibanski A (1990) Abnormal cortisol secretion and responses to corticoptropin-releasing hormone in women with hypothalamic amenorrhea. J Clin Endocrinol Metab 70:311-317.
7. Bouman TK, Luteijn F, Albersnagel FA, Ploeg FAE van der (1985) Enige ervaringen met de Beck Depression Inventory (BDI). Gedrag 13:13-24.
8. Brambilla F, Petraglia F, Facchinetti F, Genazzani A (1986) Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders. Acta Endocrinol 112:481-486.
9. Brantley PJ, Dietz LS, McKnight GT, Jones GN, Tulley R (1988) Convergence between the daily stress inventory and endocrine measures of stress. J Consult Clin Psychol 56:549-551.
10. Brenner B, Margolese R (1991) The relationship of chemo-therapeutic and endocrine intervention on natural killer cell activity in human breast cancer. Cancer 68:482-488.
11. Clevenger C, Altmann S, Prystowsky M (1991) Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes. Science 253:77-79.
12. Delahunt JW, Mellsop G (1987) Hormone changes in stress. Stress Medicine 3:123-134.
13. De Souza EB, Van Loon GR (1982) Stress-induced inhibition of the plasma corticosterone response to a subsequent stressor in rats: a nonadrenocorticotropin-mediated mechanism. Endocrinology 110:23-33.
14. Dored G, Stefansson S, d'Elia G, Kagedal B, Karlberg E, Ekman R (1990) Corticotropin, cortisol and beta-endorphin responses to the human corticotropin-releasing hormone during melancholia after unilateral electroconvulsive therapy. Acta Psychiatr Scand 82:204-209.
15. Forsyth IA (1992) The mammary gland. Baillière's Clin Endocrinol Metab 4:809-833.
16. Gaspard UJ, Romus MA, Gillain D, Duvivier J, Demey-Ponsart E, Franchimont P (1992) Plasma hormone levels in women receiving new oral contraceptives containing ethynil estradiol plus levonogestrel or desogestrel. Contraception 27:577-590.
17. Gold PW, Calabrese JR, Kling MA, Avgerinos P, Khan I, Gallucci WT, Tomai TP, Chrousos GP (1986) Abnormal ACTH and cortisol responses to ovine corticotropin releasing factor in patients with primary affective disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 10:57-65.
18. Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP (1987) Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency. Adv Biochem Psychopharmacol 43:183-200.
19. Harris B, Cook N, Warner N (1988) Anxiety and the dexamethasone suppression test monitored with saliva. Biol Psychiatry 23:698-704.
20. Hays JH, O'Brian JT (1989) Endocrine and metabolic function in patients with neoplastic disease. In: Herberman RB (Ed) Influence of the Host on Tumor Development, Kluwer Academic Publishers, Dordrecht, pp 530-543.
21. Hotta M, Shibasaki T, Masuda A (1986) The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J Clin Endocrinol Metab 62:319-324.
22. Hubert W, Nieschlag E (1988) Cortisolreaktionen im serum und speichel bei venenpunktionsstress. In: Haecke R (Ed) Speicheldiagnostik, GIT-Verlag, Darmstadt, pp 75-78.
23. Ingram DM, Nottage EM, Roberts AN (1990) Prolactin and breast cancer risk. Med J Aust 153:469-473.
24. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD (1990) Dymamics of 24-hour endogenous cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement. J Clin Endocrinol Metab 70:155-161.
25. Kirschbaum C, Hellhammer DH (1989) Salivary cortisol in psychobiological research: an overview. Neuropsychobiology 22:150-169.
26. Kitamura T, Kanos S, Shima S, Asai M (1989) Hormonal changes in major depressive disorder. Keio i Med 38:40-52.
27. Labrie F, Poulin R, Simard J, Zhao HF, Labrie C, Dauvois S, Dumont M, Hatton AC, Poirier D, Mérand Y (1990) Interactions between estrogens, androgens, progestins, and glucocorticoids in ZR-75-1 human breast cancer cells. Ann NY Acad Sci 595:130-148.
28. Labrie F, Simard J, Launoit Y de, Poulin R, Thériault C, Dumont M, Dauvois S, Martel C, Li S (1992) Androgens and breast cancer. Cancer Detect Prev 16:31-38.
29. 2 glucoprotein messenger RNA in human breast cancer cells. Breast Cancer Res Treat 3:247-258.
30. Lesch KP, Muller U, Rupprecht R, Kruse K, Schulte HM (1989) Endocrine responses to growth hormone-releasing hormone, thyrotropin-releasing hormone and corticotropin-releasing hormone in depression. Acta Psychiatr Scand 79:597-602.
31. Luger A, Deuster PA, Kyle SB, Gallucci WT, Montgomery LC, Gold PW, Loriaux DL, Chrousos GP (1987) Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med 316:1309-1315.
32. McLeod RM, Scapagnini U, Thorner MO (1985) Prolactin-Basic and Clinical Correlates. Springer, New York.
33. McNair DM, Lorr M, Droppleman LF (1971) Profile of Mood States. Educational and industrial testing service, San Diego.
34. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW (1994) Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab 79:848-853.
35. Moore JW, Thomas BS, Wang DY (1986) Endocrine status and the epidemiology and clinical course of breast cancer. Cancer Surv 3:537-559.
36. Mulligan HD, Tisdale MJ (1991) Metabolic substrate utilization by tumour and host tissues in cancer cachexia. Biochem J 277:321-326.
37. Nicolleti T, Gerli R, Orlandi S, Migliorati G, Rambotti P, Riccardi C (1989) Defective natural killer cell activity in puerperal hyperprolactinemia. J Reprod Immunol 15:113-121.
38. Oskina IN, Tinnikov AA (1992) Interaction between cortisol and cortisol-binding protein in silver foxes. Comp Biochem Physiol 101:665-668.
39. Pettingale KW, Watson M, Bhakri HL, Jones H, Tec DEH (1989) Changes in hormonal, immunological and autonomic measures during the performance of laboratory stress task. Stress Med 5:9-15.
40. Rubin R (1989) Pharmaendocrinology of major depression. Eur Arch Psychiatric Clin Neurosci 238:259-267.
41. Rupprecht R, Lesch KP, Muller U, Beck G, Beckmann H, Schulte HM (1989) Blunted adrenocorticotropin but normal beta-endorphin release after human corticotropin-releasing hormone administration in depression. J Clin Endocrinol Metab 69:600-603.
42. Saab PG, Liabre MM, Hurwitz BE, Frame CA, Reineke LJ, Fins AI, McCalla J, Cieply LK, Schneiderman N (1992) Myocardial and peripheral vascular responses to behavioral challenges and their stability in black and white Americans. Psychophysiology 29:384-397.
43. Spielberger CD (1980) Test manual for the State-Trait Anxiety Inventory -Stai form Y. Consulting Psychologist Press, Palo Alto.
44. Tichatschek E, Zielinksi C, Müller CH, Sevelda P, Kubista E, Czerwenka K, Spona J, Wolf H, Eible M (1988) Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother 27:278-282.
45. Van den Brink H, Van Wijk M, Bijlsma J (1992) Influence of steroid hormones on proliferation of peripheral blood mononuclear cells in patients with rheumatoid arthritis. Br J Rheumatol 31:663-667.
46. Van der Ploeg HM, Defares PD, Spielberger CD (1980) Handleiding bij Zelfbeoordelingsvragenlijst (ZBV) Swets and Zeitlinger, Lisse, The Netherlands.
47. Van der Pompe G, Antoni MH, Mulder CL, Heijnen C, Goodkin K, De Graeff A, Garssen B, De Vries MJ (1994) Psychoneuroimmunology and the course of breast cancer: an overview. The impact of psychosocial factors on progression of breast cancer through immune and endocrine mechanisms. Psycho-oncology 3:271-288.
48. Von Bardeleben U, Holsboer F (1988) Human corticotropin releasing hormone: clinical studies in patients with affective disorders, alcoholism, panic disorder and in normal controls. Prog Neuro Psychopharmacol Biol Psychiatry 12:S165-S187.
49. Wald FDM, Mellenberg GJ (1990) De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Ned Tijdschr Psychol 45:86-99.